BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8362248)

  • 1. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights.
    Porte RJ
    Semin Thromb Hemost; 1993; 19(3):191-6. PubMed ID: 8362248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
    Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
    Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective statistical analysis of coagulation parameters after 250 liver transplantations.
    Gerlach H; Slama KJ; Bechstein WO; Lohmann R; Hintz G; Abraham K; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):223-32. PubMed ID: 8362252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin in orthotopic liver transplantation.
    Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
    Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
    Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Blumhardt G; Kluft C; Riess H
    Semin Thromb Hemost; 1993; 19(3):311-4. PubMed ID: 7689759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in hemostasis during orthotopic liver transplantation and massive transfusion: a case report].
    Kozek-Langenecker SA; Müller CM; Felfernig M; Zimpfer M
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):296-300. PubMed ID: 8924744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis in heterotopic liver transplantation.
    Groenland TH; Porte RJ; Bakker CM; Stibbe J
    Semin Thromb Hemost; 1993; 19(3):213-7. PubMed ID: 8362250
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of aprotinin on coagulation parameters in liver transplantation.
    Welte M; Groh J; Azad S; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):297-9. PubMed ID: 7689755
    [No Abstract]   [Full Text] [Related]  

  • 11. Coagulopathy management in liver transplantation.
    Sabate A; Dalmau A; Koo M; Aparicio I; Costa M; Contreras L
    Transplant Proc; 2012; 44(6):1523-5. PubMed ID: 22841202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII activity during orthotopic liver transplantation.
    Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
    Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboelastography in liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1995; 21 Suppl 4():34-44. PubMed ID: 8747686
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulation techniques are not important in directing blood product transfusion during liver transplantation.
    Reyle-Hahn M; Rossaint R
    Liver Transpl Surg; 1997 Nov; 3(6):659-63; discussion 663-5. PubMed ID: 9404973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1995 Feb; 59(3):366-70. PubMed ID: 7532878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring blood coagulation in larger liver operations].
    Groh J; Welte M; Azad SC; Kratzer MA
    Infusionsther Transfusionsmed; 1993 Aug; 20(4):173-9. PubMed ID: 8400798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation.
    Himmelreich G; Hundt K; Bechstein WO; Rossaint R; Neuhaus P; Riess H
    Semin Thromb Hemost; 1993; 19(3):273-8. PubMed ID: 7689752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig.
    Bakker CM; Blankensteijn JD; Schlejen P; Porte RJ; Gomes MJ; Lampe HI; Stibbe J; Terpstra OT
    HPB Surg; 1994; 7(4):265-80. PubMed ID: 8204546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III replacement in orthotopic liver transplantation.
    Coccheri S; Palareti G
    Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.